Replies to post #395090 on Anavex Life Sciences Corp (AVXL)

[Dr.Oph]

Thanks
I recommend you 2018 EMA alzheimer's disease guidelines
8.1-9.3
Definition of improvement and response.
and 2022 12 03 lancet article about the lecanemab
You will know why the ema and nice should reject the monoclonal antibody treatment for alzheimer's disease